Cargando…
Role of Exosomes in Cancer-Related Cognitive Impairment
A decline in cognitive function following cancer treatment is one of the most commonly reported post-treatment symptoms among patients with cancer and those in remission, and include memory, processing speed, and executive function. A clear understanding of cognitive impairment as a result of cancer...
Autores principales: | Koh, Yong Qin, Tan, Chia Jie, Toh, Yi Long, Sze, Siu Kwan, Ho, Han Kiat, Limoli, Charles L., Chan, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215650/ https://www.ncbi.nlm.nih.gov/pubmed/32326653 http://dx.doi.org/10.3390/ijms21082755 |
Ejemplares similares
-
Extracellular Vesicle Proteome of Breast Cancer Patients with and Without Cognitive Impairment Following Anthracycline-based Chemotherapy: An Exploratory Study
por: Koh, Yong Qin, et al.
Publicado: (2021) -
Cognitive impairment in adolescent and young adult cancer patients: Pre‐treatment findings of a longitudinal study
por: Chan, Alexandre, et al.
Publicado: (2022) -
Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients
por: Ng, Ding Quan, et al.
Publicado: (2023) -
Relationship between cytokines and brain-derived neurotrophic factor (BDNF) in trajectories of cancer-related cognitive impairment
por: Yap, Ning Yi, et al.
Publicado: (2021) -
Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy
por: Toh, Yi Long, et al.
Publicado: (2022)